Assenagon Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.5M Sell
240,005
-282,776
-54% -$5.3M 0.01% 572
2025
Q1
$9.4M Buy
522,781
+112,003
+27% +$2.01M 0.02% 408
2024
Q4
$6.91M Sell
410,778
-30,987
-7% -$521K 0.01% 586
2024
Q3
$7.15M Buy
+441,765
New +$7.15M 0.01% 588
2024
Q2
Sell
-199,140
Closed -$2.95M 1440
2024
Q1
$2.95M Hold
199,140
0.01% 723
2023
Q4
$2.89M Sell
199,140
-77,844
-28% -$1.13M 0.01% 769
2023
Q3
$2.99M Sell
276,984
-85,470
-24% -$923K 0.01% 684
2023
Q2
$4.68M Buy
362,454
+231,725
+177% +$2.99M 0.02% 495
2023
Q1
$1.73M Buy
130,729
+48,243
+58% +$637K 0.01% 866
2022
Q4
$1.24M Sell
82,486
-185,499
-69% -$2.78M ﹤0.01% 945
2022
Q3
$3.16M Buy
267,985
+102,010
+61% +$1.2M 0.01% 565
2022
Q2
$1.88M Buy
165,975
+90,664
+120% +$1.02M 0.01% 835
2022
Q1
$2.25M Buy
+75,311
New +$2.25M 0.01% 767
2021
Q4
Sell
-1,353
Closed -$49K 1490
2021
Q3
$49K Hold
1,353
﹤0.01% 1226
2021
Q2
$59K Hold
1,353
﹤0.01% 1134
2021
Q1
$46K Sell
1,353
-47,562
-97% -$1.62M ﹤0.01% 1138
2020
Q4
$1.71M Sell
48,915
-6,901
-12% -$242K 0.01% 530
2020
Q3
$1.34M Buy
55,816
+33,473
+150% +$804K 0.01% 658
2020
Q2
$409K Buy
22,343
+20,747
+1,300% +$380K ﹤0.01% 959
2020
Q1
$25K Sell
1,596
-11,077
-87% -$174K ﹤0.01% 712
2019
Q4
$271K Sell
12,673
-49,327
-80% -$1.05M ﹤0.01% 668
2019
Q3
$1.16M Sell
62,000
-90,578
-59% -$1.69M 0.01% 478
2019
Q2
$3.98M Buy
152,578
+56,998
+60% +$1.49M 0.03% 302
2019
Q1
$2.46M Buy
95,580
+37,283
+64% +$958K 0.02% 422
2018
Q4
$1.34M Buy
+58,297
New +$1.34M 0.02% 530